Spontaneous clearance of Mycobacterium ulcerans in a case of Buruli Ulcer

PLoS Neglected Tropical Diseases

Volumn 5, Issue 10, 2011, Pages

  Gordon, Claire L ^a   Buntine, John A ^b,c   Hayman, John A ^c   Lavender, Caroline J ^d   Fyfe, Janet A ^d   Hosking, Patrick ^b   Johnson, Paul D R ^a,d  

^a AUSTIN HEALTH   (Australia)

^b BOX HILL HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACID FAST BACTERIUM; AGED; ARTICLE; BACTERIAL CLEARANCE; BACTERIUM CULTURE; BACTERIUM DETECTION; BURULI ULCER; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MYCOBACTERIUM ULCERANS; POLYMERASE CHAIN REACTION; CYTOCHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; LEG; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; PATHOLOGY;

AGED; BACTERIOLOGICAL TECHNIQUES; BURULI ULCER; HISTOCYTOCHEMISTRY; HUMANS; LEG; MALE; MICROSCOPY; MYCOBACTERIUM ULCERANS; POLYMERASE CHAIN REACTION;

EID: 80055090017     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001290     Document Type: Article

References (20)

1. Johnson PD, Azuolas J, Lavender CJ, Wishart E, Stinear TP, et al. (2007) Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis 13: 1653-1660.
2. Johnson PD, Hayman JA, Quek TY, Fyfe JA, Jenkin GA, et al. (2007) Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 186: 64-68.
3. Fyfe JA, Lavender CJ, Johnson PD, Globan M, Sievers A, et al. (2007) Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 73: 4733-4740.
4. Gordon CL, Buntine JA, Hayman JA, Lavender CJ, Fyfe JA, et al. (2010) All-oral antibiotic treatment for buruli ulcer: a report of four patients. PLoS Negl Trop Dis 4: e770 doi:10.1371/journal.pntd.0000770.
5. Johnson PD, (2010) Should antibiotics be given for Buruli ulcer? Lancet 375: 618-619.
6. Johnson PD, Stinear T, Small PL, Pluschke G, Merritt RW, et al. (2005) Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Med 2: e108 doi:10.1371/journal.pmed.0020108.
7. Mac CP, Tolhurst JC, et al. (1948) A new mycobacterial infection in man. J Pathol Bacteriol 60: 93-122.
8. Wansbrough-Jones M, Phillips R, (2005) Buruli ulcer. BMJ 330: 1402-1403.
9. van der Werf TS, Stienstra Y, Johnson RC, Phillips R, Adjei O, et al. (2005) Mycobacterium ulcerans disease. Bull World Health Organ 83: 785-791.
10. Hayman J, (1993) Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection. J Clin Pathol 46: 5-9.
11. Sizaire V, Nackers F, Comte E, Portaels F, (2006) Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis 6: 288-296.
12. Gooding TM, Johnson PD, Smith M, Kemp AS, Robins-Browne RM, (2002) Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun 70: 5562-5567.
13. Diaz D, Dobeli H, Yeboah-Manu D, Mensah-Quainoo E, Friedlein A, et al. (2006) Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans. Clin Vaccine Immunol 13: 1314-1321.
14. Pidot SJ, Porter JL, Marsollier L, Chauty A, Migot-Nabias F, et al. (2010) Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics. PLoS Negl Trop Dis 4: e872 doi:10.1371/journal.pntd.0000872.
15. Stienstra Y, van der Werf TS, Oosterom E, Nolte IM, van der Graaf WT, et al. (2006) Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism. Genes Immun 7: 185-189.
16. Fenner F, (1957) Homologous and heterologous immunity in infections of mice with Mycobacterium ulcerans and Mycobacterium balnei. Am Rev Tuberc 76: 76-89.
17. Thangaraj HS, Phillips RO, Evans MR, Wansbrough-Jones MH, (2003) Emerging aspects of Buruli ulcer. Expert Rev Anti Infect Ther 1: 217-222.
18. Revill WD, Morrow RH, Pike MC, Ateng J, (1973) A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet 2: 873-877.
19. Schutte D, Pluschke G, (2009) Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer). Expert Opin Biol Ther 9: 187-200.
20. Demangel C, Stinear TP, Cole ST, (2009) Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol 7: 50-60.